ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plasma Derived Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-26U7851
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Plasma Derived Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Plasma Derived Drugs Market Research Report 2025

Code: QYRE-Auto-26U7851
Report
July 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Grifols S A
Octapharma AG
CSL Limited
Takeda
Kedrion S p A
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya-Bio
Yuanda shuyang
Weiguang Bio
Nanyue Bio
KM Biologics

Plasma Derived Drugs Market Size

The global market for Plasma Derived Drugs was valued at US$ 35330 million in the year 2024 and is projected to reach a revised size of US$ 58200 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Plasma Derived Drugs Market

Plasma Derived Drugs Market

Plasma Derived Drugs: These are medicinal products that are manufactured from human plasma, the liquid component of blood. Plasma contains important proteins, clotting factors, and antibodies that can be processed and concentrated to create products used in various medical treatments. PDPs are essential for treating conditions such as hemophilia, immune deficiencies, and certain autoimmune diseases.
Driver of the Plasma Derived Drugs Market:
One of the main drivers of the Plasma Derived Drugs market is the increasing prevalence of rare and chronic diseases, such as hemophilia, primary immunodeficiency disorders, and autoimmune diseases. These conditions require ongoing treatment with Plasma Derived Drugs like clotting factors, immunoglobulins, and albumin. The growing awareness and diagnosis rates of such diseases, along with advancements in plasma collection and fractionation technologies, have contributed to a higher demand for these therapies. Additionally, increasing investments in healthcare infrastructure and government support in emerging markets are fueling market growth.
Challenge of the Plasma Derived Drugs Market:
A key challenge in this market is the complex and costly process of plasma collection and product manufacturing. Plasma Derived Drugs require large volumes of plasma, which can only be obtained through human donors. The stringent regulations surrounding plasma collection, donor screening, and testing to ensure safety make the process time-consuming and expensive. Furthermore, any disruption in plasma supply chains, such as those caused by geopolitical issues or pandemics, can lead to shortages and impact treatment availability.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Derived Drugs includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Derived Drugs market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Derived Drugs.
This report aims to provide a comprehensive presentation of the global market for Plasma Derived Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Derived Drugs.
The Plasma Derived Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasma Derived Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Derived Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Plasma Derived Drugs Market Report

Report Metric Details
Report Name Plasma Derived Drugs Market
Accounted market size in year US$ 35330 million
Forecasted market size in 2031 US$ 58200 million
CAGR 7.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Immunoglobulins
  • Albumins
  • Clotting Factors
  • Others
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Plasma Derived Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Plasma Derived Drugs Market growing?

Ans: The Plasma Derived Drugs Market witnessing a CAGR of 7.5% during the forecast period 2025-2031.

What is the Plasma Derived Drugs Market size in 2031?

Ans: The Plasma Derived Drugs Market size in 2031 will be US$ 58200 million.

What is the Plasma Derived Drugs Market share by region?

Ans: North America is the largest consumption place, with a revenue market share nearly 40% in 2023.

Who are the main players in the Plasma Derived Drugs Market report?

Ans: The main players in the Plasma Derived Drugs Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Plasma Derived Drugs Market report?

Ans: The Applications covered in the Plasma Derived Drugs Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Plasma Derived Drugs Market report?

Ans: The Types covered in the Plasma Derived Drugs Market report are Immunoglobulins, Albumins, Clotting Factors, Others

Recommended Reports

Plasma-Based Therapies

Blood Disorders Drugs

Autoimmune & Immune

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Derived Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoglobulins
1.2.3 Albumins
1.2.4 Clotting Factors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma Derived Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma Derived Drugs Market Perspective (2020-2031)
2.2 Global Plasma Derived Drugs Growth Trends by Region
2.2.1 Global Plasma Derived Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Plasma Derived Drugs Historic Market Size by Region (2020-2025)
2.2.3 Plasma Derived Drugs Forecasted Market Size by Region (2026-2031)
2.3 Plasma Derived Drugs Market Dynamics
2.3.1 Plasma Derived Drugs Industry Trends
2.3.2 Plasma Derived Drugs Market Drivers
2.3.3 Plasma Derived Drugs Market Challenges
2.3.4 Plasma Derived Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Derived Drugs Players by Revenue
3.1.1 Global Top Plasma Derived Drugs Players by Revenue (2020-2025)
3.1.2 Global Plasma Derived Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Plasma Derived Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Plasma Derived Drugs Revenue
3.4 Global Plasma Derived Drugs Market Concentration Ratio
3.4.1 Global Plasma Derived Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Derived Drugs Revenue in 2024
3.5 Global Key Players of Plasma Derived Drugs Head office and Area Served
3.6 Global Key Players of Plasma Derived Drugs, Product and Application
3.7 Global Key Players of Plasma Derived Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Derived Drugs Breakdown Data by Type
4.1 Global Plasma Derived Drugs Historic Market Size by Type (2020-2025)
4.2 Global Plasma Derived Drugs Forecasted Market Size by Type (2026-2031)
5 Plasma Derived Drugs Breakdown Data by Application
5.1 Global Plasma Derived Drugs Historic Market Size by Application (2020-2025)
5.2 Global Plasma Derived Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Plasma Derived Drugs Market Size (2020-2031)
6.2 North America Plasma Derived Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Plasma Derived Drugs Market Size by Country (2020-2025)
6.4 North America Plasma Derived Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasma Derived Drugs Market Size (2020-2031)
7.2 Europe Plasma Derived Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Plasma Derived Drugs Market Size by Country (2020-2025)
7.4 Europe Plasma Derived Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasma Derived Drugs Market Size (2020-2031)
8.2 Asia-Pacific Plasma Derived Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Plasma Derived Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Plasma Derived Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasma Derived Drugs Market Size (2020-2031)
9.2 Latin America Plasma Derived Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Plasma Derived Drugs Market Size by Country (2020-2025)
9.4 Latin America Plasma Derived Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Derived Drugs Market Size (2020-2031)
10.2 Middle East & Africa Plasma Derived Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Plasma Derived Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Plasma Derived Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Plasma Derived Drugs Introduction
11.1.4 Takeda Revenue in Plasma Derived Drugs Business (2020-2025)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Plasma Derived Drugs Introduction
11.2.4 CSL Revenue in Plasma Derived Drugs Business (2020-2025)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Details
11.3.2 Grifols Business Overview
11.3.3 Grifols Plasma Derived Drugs Introduction
11.3.4 Grifols Revenue in Plasma Derived Drugs Business (2020-2025)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Plasma Derived Drugs Introduction
11.4.4 Octapharma Revenue in Plasma Derived Drugs Business (2020-2025)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Details
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Plasma Derived Drugs Introduction
11.5.4 Kedrion Revenue in Plasma Derived Drugs Business (2020-2025)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Details
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Plasma Derived Drugs Introduction
11.6.4 LFB Group Revenue in Plasma Derived Drugs Business (2020-2025)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Plasma Derived Drugs Introduction
11.7.4 Biotest Revenue in Plasma Derived Drugs Business (2020-2025)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Details
11.8.2 BPL Business Overview
11.8.3 BPL Plasma Derived Drugs Introduction
11.8.4 BPL Revenue in Plasma Derived Drugs Business (2020-2025)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Details
11.9.2 RAAS Business Overview
11.9.3 RAAS Plasma Derived Drugs Introduction
11.9.4 RAAS Revenue in Plasma Derived Drugs Business (2020-2025)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 CBPO Business Overview
11.10.3 CBPO Plasma Derived Drugs Introduction
11.10.4 CBPO Revenue in Plasma Derived Drugs Business (2020-2025)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Details
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Plasma Derived Drugs Introduction
11.11.4 Hualan Bio Revenue in Plasma Derived Drugs Business (2020-2025)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Details
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Plasma Derived Drugs Introduction
11.12.4 Tiantan Bio Revenue in Plasma Derived Drugs Business (2020-2025)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Details
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Plasma Derived Drugs Introduction
11.13.4 Shuanglin Bio Revenue in Plasma Derived Drugs Business (2020-2025)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Details
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Plasma Derived Drugs Introduction
11.14.4 Boya Bio Revenue in Plasma Derived Drugs Business (2020-2025)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Details
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Plasma Derived Drugs Introduction
11.15.4 Yuanda Shuyang Revenue in Plasma Derived Drugs Business (2020-2025)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Details
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Plasma Derived Drugs Introduction
11.16.4 Weiguang Bio Revenue in Plasma Derived Drugs Business (2020-2025)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Details
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Plasma Derived Drugs Introduction
11.17.4 Nanyue Bio Revenue in Plasma Derived Drugs Business (2020-2025)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Details
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Plasma Derived Drugs Introduction
11.18.4 KM Biologics Revenue in Plasma Derived Drugs Business (2020-2025)
11.18.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Grifols S A
Octapharma AG
CSL Limited
Takeda
Kedrion S p A
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya-Bio
Yuanda shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
List of Tables
 Table 1. Global Plasma Derived Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Immunoglobulins
 Table 3. Key Players of Albumins
 Table 4. Key Players of Clotting Factors
 Table 5. Key Players of Others
 Table 6. Global Plasma Derived Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Plasma Derived Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Plasma Derived Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Plasma Derived Drugs Market Share by Region (2020-2025)
 Table 10. Global Plasma Derived Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Plasma Derived Drugs Market Share by Region (2026-2031)
 Table 12. Plasma Derived Drugs Market Trends
 Table 13. Plasma Derived Drugs Market Drivers
 Table 14. Plasma Derived Drugs Market Challenges
 Table 15. Plasma Derived Drugs Market Restraints
 Table 16. Global Plasma Derived Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Plasma Derived Drugs Market Share by Players (2020-2025)
 Table 18. Global Top Plasma Derived Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Drugs as of 2024)
 Table 19. Ranking of Global Top Plasma Derived Drugs Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Plasma Derived Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Plasma Derived Drugs, Headquarters and Area Served
 Table 22. Global Key Players of Plasma Derived Drugs, Product and Application
 Table 23. Global Key Players of Plasma Derived Drugs, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Plasma Derived Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Plasma Derived Drugs Revenue Market Share by Type (2020-2025)
 Table 27. Global Plasma Derived Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Plasma Derived Drugs Revenue Market Share by Type (2026-2031)
 Table 29. Global Plasma Derived Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Plasma Derived Drugs Revenue Market Share by Application (2020-2025)
 Table 31. Global Plasma Derived Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Plasma Derived Drugs Revenue Market Share by Application (2026-2031)
 Table 33. North America Plasma Derived Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Plasma Derived Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Plasma Derived Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Plasma Derived Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Plasma Derived Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Plasma Derived Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Plasma Derived Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Plasma Derived Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Plasma Derived Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Plasma Derived Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Plasma Derived Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Plasma Derived Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Plasma Derived Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Plasma Derived Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Plasma Derived Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Takeda Company Details
 Table 49. Takeda Business Overview
 Table 50. Takeda Plasma Derived Drugs Product
 Table 51. Takeda Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 52. Takeda Recent Development
 Table 53. CSL Company Details
 Table 54. CSL Business Overview
 Table 55. CSL Plasma Derived Drugs Product
 Table 56. CSL Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 57. CSL Recent Development
 Table 58. Grifols Company Details
 Table 59. Grifols Business Overview
 Table 60. Grifols Plasma Derived Drugs Product
 Table 61. Grifols Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 62. Grifols Recent Development
 Table 63. Octapharma Company Details
 Table 64. Octapharma Business Overview
 Table 65. Octapharma Plasma Derived Drugs Product
 Table 66. Octapharma Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 67. Octapharma Recent Development
 Table 68. Kedrion Company Details
 Table 69. Kedrion Business Overview
 Table 70. Kedrion Plasma Derived Drugs Product
 Table 71. Kedrion Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 72. Kedrion Recent Development
 Table 73. LFB Group Company Details
 Table 74. LFB Group Business Overview
 Table 75. LFB Group Plasma Derived Drugs Product
 Table 76. LFB Group Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 77. LFB Group Recent Development
 Table 78. Biotest Company Details
 Table 79. Biotest Business Overview
 Table 80. Biotest Plasma Derived Drugs Product
 Table 81. Biotest Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 82. Biotest Recent Development
 Table 83. BPL Company Details
 Table 84. BPL Business Overview
 Table 85. BPL Plasma Derived Drugs Product
 Table 86. BPL Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 87. BPL Recent Development
 Table 88. RAAS Company Details
 Table 89. RAAS Business Overview
 Table 90. RAAS Plasma Derived Drugs Product
 Table 91. RAAS Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 92. RAAS Recent Development
 Table 93. CBPO Company Details
 Table 94. CBPO Business Overview
 Table 95. CBPO Plasma Derived Drugs Product
 Table 96. CBPO Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 97. CBPO Recent Development
 Table 98. Hualan Bio Company Details
 Table 99. Hualan Bio Business Overview
 Table 100. Hualan Bio Plasma Derived Drugs Product
 Table 101. Hualan Bio Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 102. Hualan Bio Recent Development
 Table 103. Tiantan Bio Company Details
 Table 104. Tiantan Bio Business Overview
 Table 105. Tiantan Bio Plasma Derived Drugs Product
 Table 106. Tiantan Bio Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 107. Tiantan Bio Recent Development
 Table 108. Shuanglin Bio Company Details
 Table 109. Shuanglin Bio Business Overview
 Table 110. Shuanglin Bio Plasma Derived Drugs Product
 Table 111. Shuanglin Bio Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 112. Shuanglin Bio Recent Development
 Table 113. Boya Bio Company Details
 Table 114. Boya Bio Business Overview
 Table 115. Boya Bio Plasma Derived Drugs Product
 Table 116. Boya Bio Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 117. Boya Bio Recent Development
 Table 118. Yuanda Shuyang Company Details
 Table 119. Yuanda Shuyang Business Overview
 Table 120. Yuanda Shuyang Plasma Derived Drugs Product
 Table 121. Yuanda Shuyang Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 122. Yuanda Shuyang Recent Development
 Table 123. Weiguang Bio Company Details
 Table 124. Weiguang Bio Business Overview
 Table 125. Weiguang Bio Plasma Derived Drugs Product
 Table 126. Weiguang Bio Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 127. Weiguang Bio Recent Development
 Table 128. Nanyue Bio Company Details
 Table 129. Nanyue Bio Business Overview
 Table 130. Nanyue Bio Plasma Derived Drugs Product
 Table 131. Nanyue Bio Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 132. Nanyue Bio Recent Development
 Table 133. KM Biologics Company Details
 Table 134. KM Biologics Business Overview
 Table 135. KM Biologics Plasma Derived Drugs Product
 Table 136. KM Biologics Revenue in Plasma Derived Drugs Business (2020-2025) & (US$ Million)
 Table 137. KM Biologics Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Plasma Derived Drugs Picture
 Figure 2. Global Plasma Derived Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Plasma Derived Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Immunoglobulins Features
 Figure 5. Albumins Features
 Figure 6. Clotting Factors Features
 Figure 7. Others Features
 Figure 8. Global Plasma Derived Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Plasma Derived Drugs Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Retail Pharmacy Case Studies
 Figure 12. Other Case Studies
 Figure 13. Plasma Derived Drugs Report Years Considered
 Figure 14. Global Plasma Derived Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Plasma Derived Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Plasma Derived Drugs Market Share by Region: 2024 VS 2031
 Figure 17. Global Plasma Derived Drugs Market Share by Players in 2024
 Figure 18. Global Top Plasma Derived Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Drugs as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Plasma Derived Drugs Revenue in 2024
 Figure 20. North America Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Plasma Derived Drugs Market Share by Country (2020-2031)
 Figure 22. United States Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Plasma Derived Drugs Market Share by Country (2020-2031)
 Figure 26. Germany Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Plasma Derived Drugs Market Share by Region (2020-2031)
 Figure 34. China Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Plasma Derived Drugs Market Share by Country (2020-2031)
 Figure 42. Mexico Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Plasma Derived Drugs Market Share by Country (2020-2031)
 Figure 46. Turkey Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Plasma Derived Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Takeda Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 50. CSL Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 51. Grifols Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 52. Octapharma Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 53. Kedrion Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 54. LFB Group Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 55. Biotest Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 56. BPL Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 57. RAAS Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 58. CBPO Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 59. Hualan Bio Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 60. Tiantan Bio Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 61. Shuanglin Bio Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 62. Boya Bio Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 63. Yuanda Shuyang Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 64. Weiguang Bio Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 65. Nanyue Bio Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 66. KM Biologics Revenue Growth Rate in Plasma Derived Drugs Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tissue Based Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Electro Diagnostic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rapid Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biotherapeutics Cell Line Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Live Biotherapeutic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiological Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Polymers Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IVD Raw Materials Market Insights Forecast to 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceuticals and Biotechnology R D Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Point of Care Diagnostic and Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions